• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于将细菌抗原进行吞噬处理以呈递给T细胞的I类主要组织相容性复合体(MHC)。

Phagocytic processing of bacterial antigens for class I MHC presentation to T cells.

作者信息

Pfeifer J D, Wick M J, Roberts R L, Findlay K, Normark S J, Harding C V

机构信息

Department of Pathology, Washington University School of Medicine, St Louis, Missouri 63110.

出版信息

Nature. 1993 Jan 28;361(6410):359-62. doi: 10.1038/361359a0.

DOI:10.1038/361359a0
PMID:7678924
Abstract

Class I major histocompatibility complex (MHC) molecules present antigens that are produced within the presenting cell or penetrate from the vacuolar system into the cytosol for processing. Most studies of exogenous antigen processing have used soluble antigens, which are not efficiently presented by class I MHC molecules and do not elicit CD8 T-cell responses in vivo. But particulate antigen preparations with no known mechanism for cytosolic penetration can also elicit CD8 T-cell responses in vivo. We report here that phagocytosis of bacteria with no mechanism for cytosolic penetration also results in presentation of bacterial antigens by class I MHC molecules. Moreover, this mechanism is resistant to cycloheximide and Brefeldin A, which block the classical class I processing pathway. These results suggest a novel vacuolar class I processing pathway for exogenous phagocytic antigens.

摘要

I类主要组织相容性复合体(MHC)分子呈递在呈递细胞内产生的抗原,或从液泡系统穿透进入胞质溶胶进行加工的抗原。大多数关于外源性抗原加工的研究使用的是可溶性抗原,这类抗原不能被I类MHC分子有效呈递,且在体内不会引发CD8 T细胞反应。但没有已知胞质穿透机制的颗粒性抗原制剂在体内也能引发CD8 T细胞反应。我们在此报告,没有胞质穿透机制的细菌的吞噬作用也会导致I类MHC分子呈递细菌抗原。此外,这种机制对放线菌酮和布雷菲德菌素A具有抗性,而这两种物质会阻断经典的I类加工途径。这些结果提示了一种针对外源性吞噬抗原的新型液泡I类加工途径。

相似文献

1
Phagocytic processing of bacterial antigens for class I MHC presentation to T cells.用于将细菌抗原进行吞噬处理以呈递给T细胞的I类主要组织相容性复合体(MHC)。
Nature. 1993 Jan 28;361(6410):359-62. doi: 10.1038/361359a0.
2
Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.细菌抗原递呈系统:细菌抗原的吞噬加工,用于MHC-I和MHC-II呈递给T细胞。
Behring Inst Mitt. 1997 Feb(98):197-211.
3
Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules.巨噬细胞对外源性颗粒抗原进行吞噬处理,以便通过I类主要组织相容性复合体分子进行呈递。
J Immunol. 1994 Dec 1;153(11):4925-33.
4
Bone marrow-derived dendritic cells can process bacteria for MHC-I and MHC-II presentation to T cells.骨髓来源的树突状细胞可以处理细菌,以便将其呈递给MHC-I和MHC-II的T细胞。
J Immunol. 1997 May 1;158(9):4229-36.
5
Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T cells.肥大细胞通过吞噬途径处理细菌抗原,以便将I类主要组织相容性复合体呈递给T细胞。
J Immunol. 1996 Feb 15;156(4):1490-6.
6
Intracellular processing and presentation of T cell epitopes, expressed by recombinant Escherichia coli and Salmonella typhimurium, to human T cells.由重组大肠杆菌和鼠伤寒沙门氏菌表达的T细胞表位在细胞内的加工及呈递给人T细胞的过程。
Eur J Immunol. 1995 Feb;25(2):405-10. doi: 10.1002/eji.1830250215.
7
Recombinant Escherichia coli express a defined, cytoplasmic epitope that is efficiently processed in macrophage phagolysosomes for class II MHC presentation to T lymphocytes.重组大肠杆菌表达一种特定的细胞质表位,该表位在巨噬细胞吞噬溶酶体中被有效加工,用于将II类主要组织相容性复合体呈递给T淋巴细胞。
J Immunol. 1992 Oct 15;149(8):2576-84.
8
Processing of bacterial antigens for presentation to class I and II MHC-restricted T lymphocytes.用于呈递给I类和II类主要组织相容性复合体(MHC)限制的T淋巴细胞的细菌抗原加工过程。
Infect Agents Dis. 1995 Mar;4(1):1-12.
9
Comparison of antigen presentation of influenza A nucleoprotein expressed in attenuated AroA- Salmonella typhimurium with that of live virus.减毒AroA-鼠伤寒沙门氏菌表达的甲型流感病毒核蛋白的抗原呈递与活病毒的比较。
J Immunol. 1993 Apr 1;150(7):2869-84.
10
Processing pathways for presentation of cytosolic antigen to MHC class II-restricted T cells.将胞质抗原呈递给MHC II类限制性T细胞的加工途径。
Nature. 1992 Jun 25;357(6380):702-4. doi: 10.1038/357702a0.

引用本文的文献

1
Cross-priming in cancer immunology and immunotherapy.癌症免疫学与免疫治疗中的交叉呈递
Nat Rev Cancer. 2025 Apr;25(4):249-273. doi: 10.1038/s41568-024-00785-5. Epub 2025 Jan 29.
2
Bacterial infection and microbiota in carcinogenesis and tumor development.细菌感染与微生态在肿瘤发生和发展中的作用。
Front Cell Infect Microbiol. 2023 Nov 15;13:1294082. doi: 10.3389/fcimb.2023.1294082. eCollection 2023.
3
Modulation of T cell function and survival by the tumor microenvironment.肿瘤微环境对T细胞功能和存活的调节
Front Cell Dev Biol. 2023 May 18;11:1191774. doi: 10.3389/fcell.2023.1191774. eCollection 2023.
4
Pathways of MHC I cross-presentation of exogenous antigens.MHC I 类分子交叉呈递外源抗原的途径。
Semin Immunol. 2023 Mar;66:101729. doi: 10.1016/j.smim.2023.101729. Epub 2023 Feb 16.
5
The evolving biology of cross-presentation.交叉呈递的生物学演变。
Semin Immunol. 2023 Mar;66:101711. doi: 10.1016/j.smim.2023.101711. Epub 2023 Jan 14.
6
The Delivery of Extracellular "Danger" Signals to Cytosolic Sensors in Phagocytes.吞噬细胞中细胞外“危险”信号向胞质传感器的传递。
Front Immunol. 2022 Jul 14;13:944142. doi: 10.3389/fimmu.2022.944142. eCollection 2022.
7
DCs at the center of help: Origins and evolution of the three-cell-type hypothesis.树突状细胞处于核心地位:三细胞假说的起源和演变。
J Exp Med. 2022 Jul 4;219(7). doi: 10.1084/jem.20211519. Epub 2022 May 11.
8
Dendritic cells in cancer immunology.癌症免疫学中的树突状细胞。
Cell Mol Immunol. 2022 Jan;19(1):3-13. doi: 10.1038/s41423-021-00741-5. Epub 2021 Sep 3.
9
Virus-Induced CD8 T-Cell Immunity and Its Exploitation to Contain the SARS-CoV-2 Pandemic.病毒诱导的CD8 T细胞免疫及其在遏制SARS-CoV-2大流行中的应用
Vaccines (Basel). 2021 Aug 18;9(8):922. doi: 10.3390/vaccines9080922.
10
Combined treatment with epigenetic agents enhances anti-tumor activity of T cells by upregulating the ACRBP expression in hepatocellular carcinoma.表观遗传药物联合治疗通过上调肝细胞癌中ACRBP的表达增强T细胞的抗肿瘤活性。
Am J Transl Res. 2021 Jul 15;13(7):7591-7609. eCollection 2021.